Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. WuXi AppTec Co., Ltd.
  6. News
  7. Summary
    603259   CNE1000031K4

WUXI APPTEC CO., LTD.

(603259)
  Report
End-of-day quote. End-of-day quote Shanghai Stock Exchange - 09/27
151.6 CNY   +0.48%
09/22DMD : Charting the Path for New Therapeutics and Better Care
PU
08/25WUXI APPTEC : Investor Day - Financial Performance
PU
08/25WUXI APPTEC : Investor Day - Industry Trend and Company Strategy
PU
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2021

07/15/2021 | 06:34am EDT

WuXi AppTec Co., Ltd. provided earnings guidance for the six months ended June 30, 2021. The board of directors of the Company announced that the Company is expecting to record an increase in the net profit attributable to shareholders of the Company for the six months ended June 30, 2021 in comparison with the corresponding period of 2020. The net profit attributable to shareholders of the Company was estimated to increase by a range between RMB 910.0924 million to RMB 944.4355 million for the first half of 2021.


ę S&P Capital IQ 2021
All news about WUXI APPTEC CO., LTD.
09/22DMD : Charting the Path for New Therapeutics and Better Care
PU
08/25WUXI APPTEC : Investor Day - Financial Performance
PU
08/25WUXI APPTEC : Investor Day - Industry Trend and Company Strategy
PU
08/25WUXI APPTEC : Investor Day - WuXi Biology
PU
08/25WUXI APPTEC : Investor Day - WuXi Chemistry
PU
08/25WUXI APPTEC : Investor Day - WuXi Testing
PU
08/13WUXI APPTEC : H1 Profit Surges 56% on Strong Revenue
MT
08/12WuXi AppTec Co., Ltd. Announces Earnings Results for the Half Year Ended June 30, 2021
CI
08/12WUXI APPTEC : Reports Strong 2021 Interim Results
PU
08/03WUXI APPTEC : STA Completes Acquisition of Bristol Myers Squibb Manufacturing Facility in ..
PU
More news
Analyst Recommendations on WUXI APPTEC CO., LTD.
More recommendations
Financials
Sales 2021 22 383 M 3 466 M 3 466 M
Net income 2021 4 418 M 684 M 684 M
Net cash 2021 9 114 M 1 411 M 1 411 M
P/E ratio 2021 98,7x
Yield 2021 0,26%
Capitalization 447 B 69 209 M 69 207 M
EV / Sales 2021 19,6x
EV / Sales 2022 14,8x
Nbr of Employees 28 542
Free-Float 56,7%
Chart WUXI APPTEC CO., LTD.
Duration : Period :
WuXi AppTec Co., Ltd. Technical Analysis Chart | 603259 | CNE1000031K4 | MarketScreener
Technical analysis trends WUXI APPTEC CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 151,60 CNY
Average target price 185,83 CNY
Spread / Average Target 22,6%
EPS Revisions
Managers and Directors
Min Zhang Chen Co-Chief Executive Officer
Qing Yang Co-CEO, Executive Director & Executive VP
Ge Li Chairman & President
Ellis Chu Chief Financial Officer & Senior Vice President
Harry He Chairman-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
WUXI APPTEC CO., LTD.35.04%69 209
GILEAD SCIENCES, INC.20.85%88 281
BIONTECH SE276.71%74 169
REGENERON PHARMACEUTICALS28.14%64 363
VERTEX PHARMACEUTICALS-22.40%47 582
BEIGENE, LTD.45.97%35 092